DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy patch mends wounds in rare 'butterfly skin' disease
Disease control OngoingThis study tests a treatment called D-Fi, made from a patient's own skin cells that are genetically modified to produce a missing protein. It aims to improve wound healing in children and adults with dystrophic epidermolysis bullosa, a condition that causes fragile, blistering sk…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New eye drops aim to shed light on EB-Related eye pain
Symptom relief OngoingThis study tests whether ELK-003 eye drops can safely reduce eye symptoms in people with certain types of epidermolysis bullosa (EB), a rare skin condition that also affects the eyes. About 20 participants will first be observed without treatment, then receive the eye drops six t…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC